Gw Henssler & Associates LTD Amgen Inc Transaction History

Gw Henssler & Associates LTD

$1.67 Billion
Q1 2024

A detailed history of Gw Henssler & Associates LTD transactions in Amgen Inc stock. As of the latest transaction made, Gw Henssler & Associates LTD holds 94,658 shares of AMGN stock, worth $29.6 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares

94,658

Previous 95,163 0.53%

Holding current value

$29.6 Million

Previous $27.4 Million 1.81%

% of portfolio

1.61%

Previous 1.85%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $135,779 - $163,902	-505 Reduced 0.53%	94,658 $26.9 Million
Q4 2023 Jan 26, 2024	SELL	$255.7 - $288.46 $459,237 - $518,074	-1,796 Reduced 1.85%	95,163 $27.4 Million
Q3 2023 Oct 24, 2023	SELL	$218.65 - $271.46 $191,100 - $237,256	-874 Reduced 0.89%	96,959 $26.1 Million
Q2 2023 Aug 02, 2023	BUY	$214.27 - $253.37 $173,344 - $204,976	809 Added 0.83%	97,833 $21.7 Million
Q1 2023 Apr 26, 2023	BUY	$225.79 - $275.2 $295,784 - $360,512	1,310 Added 1.37%	97,024 $23.5 Million

Q4 2022 Feb 03, 2023	SELL	$229.03 - $291.01 $34,125 - $43,360	-149 Reduced 0.16%	95,714 $25.1 Million
Q3 2022 Nov 04, 2022	BUY	$224.46 - $253.15 $470,468 - $530,602	2,096 Added 2.24%	95,863 $21.6 Million
Q2 2022 Aug 04, 2022	BUY	$230.71 - $256.74 $377,441 - $420,026	1,636 Added 1.78%	93,767 $22.8 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $1.42 Million - $1.57 Million	6,458 Added 7.54%	92,131 $22.3 Million
Q4 2021 Jan 28, 2022	SELL	$198.88 - $227.6 $108,190 - $123,814	-544 Reduced 0.63%	85,673 $19.3 Million
Q3 2021 Nov 02, 2021	BUY	$212.27 - $248.7 $1.46 Million - $1.72 Million	6,898 Added 8.7%	86,217 $18.3 Million
Q2 2021 Aug 09, 2021	BUY	$233.58 - $259.14 $542,372 - $601,723	2,322 Added 3.02%	79,319 $19.3 Million
Q1 2021 Apr 28, 2021	BUY	$221.91 - $258.6 $548,117 - $638,742	2,470 Added 3.31%	76,997 $19.2 Million
Q4 2020 Feb 02, 2021	BUY	$216.38 - $257.67 $266,796 - $317,707	1,233 Added 1.68%	74,527 $17.1 Million
Q3 2020 Oct 22, 2020	BUY	$234.65 - $260.95 $169,886 - $188,927	724 Added 1.0%	73,294 $18.6 Million
Q2 2020 Jul 21, 2020	BUY	$197.81 - $242.74 $1.08 Million - $1.32 Million	5,451 Added 8.12%	72,570 $17.1 Million
Q1 2020 Apr 27, 2020	BUY	$182.24 - $241.7 $2.62 Million - $3.48 Million	14,384 Added 27.28%	67,119 $13.6 Million
Q4 2019 Feb 24, 2020	BUY	$189.21 - $243.2 $718,051 - $922,944	3,795 Added 7.75%	52,735 $12.7 Million
Q3 2019 Nov 18, 2019	BUY	$174.11 - $208.62 $8.52 Million - $10.2 Million	48,940 New	48,940 $9.47 Million
Q4 2018 Jan 22, 2019	SELL	$178.4 - $208.25 $207,300 - $241,986	-1,162 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$185.29 - $208.89 $3,705 - $4,177	-20 Reduced 1.69%	1,162 $241,000
Q2 2018 Aug 06, 2018	BUY	$166.05 - $186.51 $196,271 - $220,454	1,182 New	1,182 $218,000
Q4 2017 Feb 06, 2018	SELL	$168.79 - $188.59 $199,509 - $222,913	-1,182 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$167.29 - $191.0 $197,736 - $225,762	1,182	1,182 $220,000

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw Henssler & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gw Henssler & Associates LTD with notifications on news.

Account

Gw Henssler & Associates LTD Amgen Inc Transaction History